Illumina's (ILMN) recently-signed partnership to distribute Thermo Fisher's Ion AmpliSeq technology is encouraging.
Российские ученые хотят коммерциализовать новый латеральный проточный иммуноанализ для диагностики инфаркта и сепсиса
Изобретатели получили патент на эту технологию в России, но не добились для нее защиты где-нибудь еще. Патент RU2510510C1, «Тест-система для полуколичественного иммунохроматографического анализа», описывает пластиковую подложку с поверхностью, покрытой аналитической мембраной, на которой «сформировано от 2 до 10 дискретных параллельных тестовых линий путем предварительного нанесения на мембрану растворов вторых специфических моноклональных антител против определяемого соединения, причем концентрация антител последовательно возрастает от линии к линии».
Today, Speaker Ryan discussed how each day, more Americans are benefiting from the new tax law: “Yesterday, the president was in Ohio to talk about the good news still rolling in on tax reform. Just over this past week, companies like UPS, Lowe’s, Cigna, Thermo Fisher Scientific, and Best Buy announced bonuses, they announced pay raises, they announced additional benefits for their employees. “Right now, thanks to tax reform, companies have announced more than $2.5 billion in bonuses and $179.5 billion in new investments in this country already. More than 4.3 million workers have benefited. And of course, as a result of tax reform, the average family of four will save more than $2,000 this year. Tax reform is working. “And there have been significant economic gains. U.S. employers added 200,000 jobs in January, with wages growing at the biggest rate in eight years. Unemployment is at a 17-year low, and tax cuts are only going to help raise wages and create more good jobs. Speaker Ryan also discussed the Democrats’ ongoing strategy to hold government funding hostage: “Finally, as was mentioned by the majority leader and others, we are voting on yet another continuing resolution this week. I will remind you that the only reason we do not have a full budget agreement is because Democrats continue to hold funding for our government hostage on an unrelated issue. They must stop using our troops as pawns in a game of politics, and that’s why the House will send the Senate a bill to fully fund our military for this year while we keep working toward a budget agreement. “I urge the Senate Democrats to stop their filibuster and provide our men and women in uniform the resources that they need, they support that they need. Quite literally, the safety of our service members and the security of our country is at stake.”
Yesterday, President Trump visited Sheffer Corp. in Blue Ash, Ohio to tout the early benefits of tax reform sweeping the country. Sheffer, a hydraulic and pneumatic cylinders manufacturer, is home to 126 employees—all of whom received $1,000 bonuses following the enactment of the Tax Cuts and Jobs Act. As the company’s President and CEO, Jeff Norris, said before the speech, “Some people have said that’s ‘crumbs,’ but for the Sheffer people, we consider that fine dining.” The president’s visit could not have come at a better time. Just last week, UPS, Lowe’s, Cigna, Thermo Fisher Scientific, and Hostess announced new rewards for their employees' due at least in part to tax reform. Yesterday, Anthem announced it will make $1,000 contributions to their employees 401(k) accounts. And this month, as new withholding tables take effect, 90 percent of Americans will see more take-home pay in their paychecks thanks to the Tax Cuts and Jobs Act. The average family of four will save more than $2,000 this year alone. Where Democrats see “crumbs,” Americans are seeing more money in their pockets as a result of the new law. From bonuses to wage increases and higher 401(k) contributions, tax reform is making life easier for hardworking people and families nationwide. And that’s what this is really all about.
Thermo Fisher's (TMO) acquisition of FEI Company already adds capabilities to its analytical instruments portfolio. Also, solid cash in hand enables the company to yield fat returns to investors.
In the last 24 hours, there has been more good news spurred on by the Tax Cuts and Jobs Act, passed by Congress and signed into law right before Christmas. UPS: Today, UPS announced more than $12 billion in investments to expand the company’s Smart Logistics Network, significantly increase pension funding, and position the company to further enhance shareholder value. Lowe's: Also today, Lowe's announced it would provide bonuses for more than 260,000 hourly employees and expand its benefits package. Cigna: Yesterday, Cigna announced it would raise their minimum wage, provide $15 million in salary raises, add $30 million to the 401k program, and make additional investments to its foundation. Thermo Fisher Scientific: And finally, Thermo Fisher Scientific announced yesterday it will make investments totaling $50 million in its people and the U.S., including $34 million for a $500 bonus for its 68,000 employees and $16 million to invest in R&D and STEM programs. All of these companies credited the new tax reform law for these actions that will benefit their employees and the United States. Yesterday, a new Monmouth poll came out showing the favorability of the tax reform law is way up. In December, 26% of Americans approved of the bill and 47% disapproved. But now 44% approve and 44% disapprove. That’s a swing of 21 points. Americans are really starting to get it. That’s in large part because the benefits of tax reform are being heard, seen, and felt by Americans around the country. The poll also dived into those Americans who believed their taxes would go up: “Perhaps more importantly, fewer Americans (36%) believe that their own federal taxes will go up under the plan than felt the same when the bill was in its final legislative stages last month (50%).” The reality is even better. When the Treasury Department instructed the IRS to activate the new withholding tables, it estimated that 90 percent of wage-earners will experience an increase in their take-home pay. So more good news is coming for Americans across the country.
Today, Thermo Fisher Scientific announced that it will invest an additional $50 million in the United States following enactment of the Tax Cuts and Jobs Act. Read the full press release here or below: Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will make additional investments totaling $50 million as a result of the benefit of recently enacted Federal tax reform legislation in the U.S. This investment includes: $34 million for a one-time bonus of $500 to be paid to each of the company's approximately 68,000 eligible non-executive employees globally; $16 million to accelerate key breakthrough R&D programs and also to increase the impact of the company's sustainability initiatives and philanthropic activities in support of STEM (Science, Technology, Engineering and Math) education. "Thermo Fisher will benefit from tax reform, so we chose to use this unique opportunity to recognize the commitment of our colleagues who work hard every day to fulfill our Mission – to enable our customers to make the world healthier, cleaner and safer," said Marc N. Casper, president and chief executive officer, Thermo Fisher Scientific. "We also plan to use the benefit to fuel important programs that will strengthen our ability to serve our customers and the communities where we live and work."
Thermo Fisher (TMO) registers a solid international performance in Q4 with strong year-over-year growth in the Asia-Pacific and the emerging markets of China, South Korea and the Middle East.
Thermo Fisher (TMO) rides high on strength in all segments in Q4.
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Illumina (ILMN) consistently tries to enhance NGS platform.
Illumina (ILMN) consistently tries to enhance NGS platform.
The FDA has approved label expansion of four different drugs from Roche, Exelixis, Pfizer and Bristol-Myers. However, Celgene faced a setback as Revlimid failed in a phase III study.
Малые и крупные компании соревнуются друг с другом в том, чтобы найти спасение от редких генетических мутаций, вызывающих рак
Which stock wins in a head-to-head match-up between these two gene-sequencing leaders?